Complement C3 and C-reactive protein in male survivors of myocardial infarction

被引:42
作者
Carter, Angela M. [1 ]
Prasad, Usha K. [1 ]
Grant, Peter J. [1 ]
机构
[1] Univ Leeds, Div Cardiovasc & Diabet Res, Light Labs, Leeds LS2 9JT, W Yorkshire, England
关键词
Complement C3; C-reactive protein; Myocardial infarction; CORONARY-ARTERY-DISEASE; POPULATION-BASED COHORT; RISK-FACTOR; SERUM C3; PLASMA; MEN; COLOCALIZATION; ATORVASTATIN; ASSOCIATION; CHOLESTEROL;
D O I
10.1016/j.atherosclerosis.2008.07.007
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background: Inflammatory processes play a fundamental role in the development of cardiovascular disease. Objectives: To compare the associations of complement C3 and C-reactive protein (CRP) with myocardial infarction (MI) and cardiovascular risk factors. Methods: 342 Caucasian male subjects aged <= 65 years with MI and 193 Caucasian age matched healthy male control subjects were recruited. C3 and CRP were measured by ELISA. Results: C3 and CRP were significantly higher (p<0.001) in patients compared with healthy subjects (patients vs. healthy subjects, C3: 1.22 gL(-1) vs. 1.00gL(-1); CRP: 1.41 mg L-1 vs. 0.72 mg L-1). In a logistic regression model, including conventional cardiovascular risk factors, C3 was independently associated with MI (odds ratio fora 1 S.D. increase in C3: 2.29[1.58, 2.92]); and this association remained after including CRP and/or fibrinogen in the model. CRP was independently associated with MI after accounting for conventional risk factors (odds ratio for a I S.D. increase in CRP: 1.47 [1.16,1.87]), however, this association was lost when C3 and/or fibrinogen were included in the model. Receiver operating characteristic (ROC) analysis indicated that the model which best predicted MI was the model including C3 and fibrinogen. Conclusions: These data suggest that elevated C3 is independently associated with MI and that elevated C3 may be a more specific marker of the inflammatory processes underpinning MI than CRP. (C) 2008 Published by Elsevier Ireland Ltd.
引用
收藏
页码:538 / 543
页数:6
相关论文
共 28 条
[1]
Complement C3 and C-reactive protein levels in patients with stable coronary artery disease [J].
Ajjan, R ;
Grant, PJ ;
Futers, TS ;
Brown, JM ;
Cymbalista, CM ;
Boothby, M ;
Carter, AM .
THROMBOSIS AND HAEMOSTASIS, 2005, 94 (05) :1048-1053
[2]
ANDO B, 1988, J BIOL CHEM, V263, P11907
[3]
Carter Angela M, 2005, Diab Vasc Dis Res, V2, P113, DOI 10.3132/dvdr.2005.018
[4]
CHOY LN, 1992, J BIOL CHEM, V267, P12736
[5]
Acylation stimulating protein (ASP), an adipocyte autocrine: new directions [J].
Cianflone, K ;
Maslowska, M ;
Sniderman, AD .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 1999, 10 (01) :31-41
[6]
Weight gain in relation to plasma levels of complement factor 3:: results from a population-based cohort study [J].
Engström, G ;
Hedblad, B ;
Janzon, L ;
Lindgärde, F .
DIABETOLOGIA, 2005, 48 (12) :2525-2531
[7]
Complement C3 is a risk factor for the development of diabetes -: A population-based cohort study [J].
Engström, G ;
Hedblad, B ;
Eriksson, KF ;
Janzon, L ;
Lindgärde, F .
DIABETES, 2005, 54 (02) :570-575
[8]
Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke:: a population-based cohort study [J].
Engstrom, Gunnar ;
Hedblad, Bo ;
Janzon, Lars ;
Lindgarde, Folke .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2007, 14 (03) :392-397
[9]
Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease - Effects of expanded-dose simvastatin [J].
Halkes, CJM ;
van Dijk, H ;
de Jaegere, PPT ;
Plokker, HWM ;
van der Helm, Y ;
Erkelens, DW ;
Cabezas, MC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (09) :1526-1530
[10]
Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction [J].
Laine, P ;
Pentikäinen, MO ;
Würzner, R ;
Penttilä, A ;
Paavonen, T ;
Meri, S ;
Kovanen, PT .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (04) :404-+